Condition
Acute Exacerbation of Bronchiectasis
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown3
Clinical Trials (3)
Showing 3 of 3 trials
NCT05313750Phase 4UnknownPrimary
Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults
NCT04098094Unknown
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
NCT02765295Not ApplicableUnknown
Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study
Showing all 3 trials